ArticleJournal of clinical pharmacology2026

Evaluating the Impact of Enfortumab Vedotin Dose Modifications on Clinical Efficacy Using Tumor Growth Inhibition Modeling in Patients With Advanced Urothelial Cancer.

Vaishali L Chudasama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.